Please login to the form below
Dukoral
This page shows the latest Dukoral news and features for those working in and with pharma, biotech and healthcare.
FDA approves first cholera vaccine in US
The approval also comes against the backdrop of a worldwide shortage in oral cholera vaccines, which include Valneva's Dukoral and the International Vaccine Institute's Shanchol.
Latest news
-
Of hobbits and healthcare
New Zealand has gained repute for doing cool stuff in the film world, now native Kiwi David Anderson comes up with some of his gems in healthcare advertising
-
Langland dominates IPA Best of Health Awards
Saatchi and Saatchi Health, Sydney. Chained - Train Station. Dukoral. Saatchi and Saatchi Health, Sydney. ... Chained - Tuk Tuk. Dukoral. Saatchi and Saatchi Health, Sydney. Pole to Pole – Joggers.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary plus benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Senior Copywriter
-
Salary TBC
-
Events Executive
-
DOE
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- UCB gets bigger in rare diseases with $2.1bn purchase of Ra Pharma
- J&J hit by $8bn judgment for man claiming breast growth due to Risperdal
- Gilead builds case for Xeljanz rival filgotinib as it preps US filing
- PMLiVE launches its inaugural T40
- Horizon shares data on eye disease drug as FDA decision nears
- Tranexamic acid linked to lower death rate in some brain injury patients
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- PANDAS/PANS Awareness: A parent’s story
- Leading AstraZeneca’s return to growth in Europe
PMHub
Cello Health
Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...
Latest intelligence
- PANDAS/PANS Awareness: A parent’s story
- To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
- Leading AstraZeneca’s return to growth in Europe
- PME talks to Iskra Reic, the company’s head of Europe and Canada...
- The era of digital wellbeing
- Social media - friend or foe?...
Quick links
Infographics
